ATLANTA, GA – – (Newsfile Corp. – March 31, 2022) – – Holzer & Holzer, LLC is investigating whether NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) complied with federal securities laws. On March 28, 2022, the Company announced that its CEO was stepping down and further disclosed that it expects “revenue for Q1 2022 may be below the low end of its prior guidance of $118 – $120 million and EBITDA for Q1 2022 will be below the low end of its prior guidance of $(15) – $(12) million.” Following this announcement, the Company’s stock price dropped. If you purchased NeoGenomics stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.